Blood Cancer UK Research

Analysis

Blood Cancer UK Research is a registered charity in England and Wales, based in Edinburgh. It was registered in November 1962, 64 years ago. Its declared purposes cover the advancement of health or saving of lives, which this site groups under health and saving lives. Legally it is a charitable company (Companies House number 00738089). It says it makes grants to organisations, provides services and provides advocacy/advice/information.

In the financial year ending March 2025, Blood Cancer UK Research reported income of £21.1m and spending of £20.2m, spending 96% of its income. Across the 5 years on record, from March 2021 to March 2025, income grew from £12.5m to £21.1m (+69%), an average of +14% a year. The sharpest change came in the year to March 2023, when income rose by 41%. Over the whole period it spent 88% of the income it received.

Among 24,651 England and Wales charities whose main cause is health and saving lives and that reported income, Blood Cancer UK Research sits at the 99th percentile: it is one of the largest 1% in its cause. Against every charity in England and Wales with reported income it ranks in the 100th percentile. Charities of a similar size with the same main cause include Penrose Options (£20.9m), Teenage Cancer Trust (£21.1m) and North West Lung Centre (£20.9m).

In its latest detailed accounts, income came from donations and legacies 87%, investments 6.4% and trading 4.1%. Gifts in wills alone brought in £7.5m. Charitable activities took 67% of spending and raising funds 32%. Grants to other organisations totalled £10.1m. Reserves of £4.5m would cover about 3 months of spending at that rate. It employed 131 people.